SIRT1 and neoplasm: The abundance or activity of SIRT1 has been reported to decrease or increase in tissues following treatment with HFD [22], [48] or resveratrol [52]–[54] respectively, so we set out to determine if the tumor promoting or inhibiting effects of these treatments on oncogenesis is dependent on SIRT1.